By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Research, development and eventual commercialization of precision oncology drugs targeting specific11.62M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Switzerland50.89M95.16%
United States2.59M4.84%